AC Immune SA (ACIU)
2.935
+0.08
(+2.62%)
USD |
NASDAQ |
Aug 25, 16:00
2.935
0.00 (0.00%)
After-Hours: 19:04
AC Immune Market Cap : 267.38M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 260.54M |
| August 21, 2026 | 264.19M |
| August 20, 2026 | 240.50M |
| August 19, 2026 | 235.04M |
| August 18, 2026 | 234.13M |
| August 17, 2026 | 230.48M |
| August 14, 2026 | 226.84M |
| August 13, 2026 | 234.13M |
| August 12, 2026 | 238.68M |
| August 11, 2026 | 231.39M |
| August 10, 2026 | 207.71M |
| August 07, 2026 | 215.00M |
| August 06, 2026 | 211.35M |
| August 05, 2026 | 208.62M |
| August 04, 2026 | 206.28M |
| August 03, 2026 | 225.87M |
| July 31, 2026 | 222.82M |
| July 30, 2026 | 241.13M |
| July 29, 2026 | 230.95M |
| July 28, 2026 | 236.04M |
| July 27, 2026 | 234.01M |
| July 24, 2026 | 226.89M |
| July 23, 2026 | 227.90M |
| July 22, 2026 | 230.95M |
| July 21, 2026 | 234.01M |
| Date | Value |
|---|---|
| July 20, 2026 | 228.92M |
| July 17, 2026 | 223.83M |
| July 16, 2026 | 221.80M |
| July 15, 2026 | 240.11M |
| July 14, 2026 | 245.20M |
| July 13, 2026 | 249.27M |
| July 10, 2026 | 243.16M |
| July 09, 2026 | 264.53M |
| July 08, 2026 | 256.39M |
| July 07, 2026 | 258.43M |
| July 06, 2026 | 255.37M |
| July 02, 2026 | 255.37M |
| July 01, 2026 | 242.15M |
| June 30, 2026 | 242.15M |
| June 29, 2026 | 270.63M |
| June 26, 2026 | 260.46M |
| June 25, 2026 | 249.27M |
| June 24, 2026 | 258.43M |
| June 23, 2026 | 249.27M |
| June 22, 2026 | 254.36M |
| June 18, 2026 | 244.18M |
| June 17, 2026 | 238.08M |
| June 16, 2026 | 241.13M |
| June 15, 2026 | 238.08M |
| June 12, 2026 | 235.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Basilea Pharmaceutica AG | 959.99M |
| Santhera Pharmaceuticals Holding AG | 311.40M |
| BeOne Medicines Ltd. | 39.26B |
| CRISPR Therapeutics AG | 5.880B |
| Idorsia Ltd. | 1.907B |
Market Cap Related Metrics
| PS Ratio | 12.72 |
| Price to Book Value | 6.133 |
| Price | 2.935 |
| Earnings Yield | -18.94% |